Lactate Biomarker May Predict Outcomes in Cardiogenic Shock - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Lactate Biomarker May Predict Outcomes in Cardiogenic Shock

A review of cardiogenic shock studies suggests serial lactate measurements provide more prognostic information than isolated values and may better reflect treatment response.

  • By

  • Andrea Surnit

  • June 23, 2026

  • 4 min

Share

Clinical Scorecard: Lactate Biomarker May Predict Outcomes in Cardiogenic Shock

At a Glance

CategoryDetail
ConditionCardiogenic Shock
Key MechanismsReduced cardiac output, systemic hypoperfusion, adrenergic stimulation, ischemia-reperfusion injury, systemic inflammation, mitochondrial dysfunction, impaired hepatic or renal clearance.
Target PopulationPatients with cardiogenic shock
Care SettingIntensive care and emergency settings

Key Highlights

  • Admission lactate levels are associated with shock severity and mortality.
  • Lactate thresholds of 3 to 3.5 mmol/L indicate higher short-term mortality risk.
  • Serial lactate monitoring reflects metabolic recovery and response to therapy.
  • Early lactate clearance is a strong predictor of survival post-VA-ECMO initiation.
  • Lactate should be interpreted as a dynamic biomarker reflecting metabolic stress and clearance.

Guideline-Based Recommendations

Diagnosis

  • Use admission lactate levels to assess shock severity.

Management

  • Monitor lactate levels serially to guide treatment and assess recovery.

Monitoring & Follow-up

  • Track lactate clearance within the first 24 hours for survival prediction.

Risks

  • Persistent hyperlactatemia despite adequate device flow is associated with poor outcomes.

Patient & Prescribing Data

Patients undergoing treatment for cardiogenic shock, including those receiving VA-ECMO.

Epinephrine may elevate lactate levels, complicating clinical interpretation.

Clinical Best Practices

  • Integrate lactate values with clinical context for accurate assessment.
  • Consider trajectory-based lactate assessment for risk stratification.

Related Resources & Content

Original Source(s)

Lactate Biomarker May Predict Outcomes in Cardiogenic Shock

  • by Andrea Surnit

  • June 23, 2026

Related Content

AI Tool Finds More Long COVID Cases Than Codes

Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.

Recurrent Pulseless Electrical Activity Arrests Due to Coronary Vasospasm Without Obstructive Coronary Artery Disease

  • July 7, 2026

FDA Approves New Iohexol Vials

The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.